Daclizumab improves control of chronic persistent asthma

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2004

Schlagwörter:	Asthma Salbutamol Triamcinolone Systemic Corticosteroid Daclizumab

Anmerkung:	© Adis International Ltd 2004

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1437(2004), 1 vom: Mai, Seite 9-10
Übergeordnetes Werk:	volume:1437 ; year:2004 ; number:1 ; month:05 ; pages:9-10

Links:	Volltext

DOI / URN:	10.2165/00128413-200414370-00020

Katalog-ID:	SPR03518681X

Internformat


LEADER	01000caa a22002652 4500
001	SPR03518681X
003	DE-627
005	20230520004635.0
007	cr uuu---uuuuu
008	201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200414370-00020 \|2 doi
035			\|a (DE-627)SPR03518681X
035			\|a (SPR)00128413-200414370-00020-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Daclizumab improves control of chronic persistent asthma
264		1	\|c 2004
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2004
650		4	\|a Asthma \|7 (dpeaa)DE-He213
650		4	\|a Salbutamol \|7 (dpeaa)DE-He213
650		4	\|a Triamcinolone \|7 (dpeaa)DE-He213
650		4	\|a Systemic Corticosteroid \|7 (dpeaa)DE-He213
650		4	\|a Daclizumab \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1437(2004), 1 vom: Mai, Seite 9-10 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1437 \|g year:2004 \|g number:1 \|g month:05 \|g pages:9-10
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200414370-00020 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1437 \|j 2004 \|e 1 \|c 05 \|h 9-10

Indexfelder

matchkey_str	article:22306056:2004----::alzmbmrvsotoocrnce
hierarchy_sort_str	2004
publishDate	2004
allfields	10.2165/00128413-200414370-00020 doi (DE-627)SPR03518681X (SPR)00128413-200414370-00020-e DE-627 ger DE-627 rakwb eng Daclizumab improves control of chronic persistent asthma 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Asthma (dpeaa)DE-He213 Salbutamol (dpeaa)DE-He213 Triamcinolone (dpeaa)DE-He213 Systemic Corticosteroid (dpeaa)DE-He213 Daclizumab (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1437(2004), 1 vom: Mai, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1437 year:2004 number:1 month:05 pages:9-10 https://dx.doi.org/10.2165/00128413-200414370-00020 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1437 2004 1 05 9-10
spelling	10.2165/00128413-200414370-00020 doi (DE-627)SPR03518681X (SPR)00128413-200414370-00020-e DE-627 ger DE-627 rakwb eng Daclizumab improves control of chronic persistent asthma 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Asthma (dpeaa)DE-He213 Salbutamol (dpeaa)DE-He213 Triamcinolone (dpeaa)DE-He213 Systemic Corticosteroid (dpeaa)DE-He213 Daclizumab (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1437(2004), 1 vom: Mai, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1437 year:2004 number:1 month:05 pages:9-10 https://dx.doi.org/10.2165/00128413-200414370-00020 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1437 2004 1 05 9-10
allfields_unstemmed	10.2165/00128413-200414370-00020 doi (DE-627)SPR03518681X (SPR)00128413-200414370-00020-e DE-627 ger DE-627 rakwb eng Daclizumab improves control of chronic persistent asthma 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Asthma (dpeaa)DE-He213 Salbutamol (dpeaa)DE-He213 Triamcinolone (dpeaa)DE-He213 Systemic Corticosteroid (dpeaa)DE-He213 Daclizumab (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1437(2004), 1 vom: Mai, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1437 year:2004 number:1 month:05 pages:9-10 https://dx.doi.org/10.2165/00128413-200414370-00020 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1437 2004 1 05 9-10
allfieldsGer	10.2165/00128413-200414370-00020 doi (DE-627)SPR03518681X (SPR)00128413-200414370-00020-e DE-627 ger DE-627 rakwb eng Daclizumab improves control of chronic persistent asthma 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Asthma (dpeaa)DE-He213 Salbutamol (dpeaa)DE-He213 Triamcinolone (dpeaa)DE-He213 Systemic Corticosteroid (dpeaa)DE-He213 Daclizumab (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1437(2004), 1 vom: Mai, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1437 year:2004 number:1 month:05 pages:9-10 https://dx.doi.org/10.2165/00128413-200414370-00020 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1437 2004 1 05 9-10
allfieldsSound	10.2165/00128413-200414370-00020 doi (DE-627)SPR03518681X (SPR)00128413-200414370-00020-e DE-627 ger DE-627 rakwb eng Daclizumab improves control of chronic persistent asthma 2004 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2004 Asthma (dpeaa)DE-He213 Salbutamol (dpeaa)DE-He213 Triamcinolone (dpeaa)DE-He213 Systemic Corticosteroid (dpeaa)DE-He213 Daclizumab (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1437(2004), 1 vom: Mai, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1437 year:2004 number:1 month:05 pages:9-10 https://dx.doi.org/10.2165/00128413-200414370-00020 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1437 2004 1 05 9-10
language	English
source	Enthalten in Inpharma weekly 1437(2004), 1 vom: Mai, Seite 9-10 volume:1437 year:2004 number:1 month:05 pages:9-10
sourceStr	Enthalten in Inpharma weekly 1437(2004), 1 vom: Mai, Seite 9-10 volume:1437 year:2004 number:1 month:05 pages:9-10
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Asthma Salbutamol Triamcinolone Systemic Corticosteroid Daclizumab
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2004-05-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR03518681X
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03518681X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520004635.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414370-00020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03518681X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414370-00020-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Daclizumab improves control of chronic persistent asthma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Asthma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Salbutamol</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Triamcinolone</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Systemic Corticosteroid</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Daclizumab</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1437(2004), 1 vom: Mai, Seite 9-10</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1437</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:9-10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414370-00020</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1437</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">05</subfield><subfield code="h">9-10</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Daclizumab improves control of chronic persistent asthma Asthma (dpeaa)DE-He213 Salbutamol (dpeaa)DE-He213 Triamcinolone (dpeaa)DE-He213 Systemic Corticosteroid (dpeaa)DE-He213 Daclizumab (dpeaa)DE-He213
topic	misc Asthma misc Salbutamol misc Triamcinolone misc Systemic Corticosteroid misc Daclizumab
spellingShingle	misc Asthma misc Salbutamol misc Triamcinolone misc Systemic Corticosteroid misc Daclizumab Daclizumab improves control of chronic persistent asthma
topic_unstemmed	misc Asthma misc Salbutamol misc Triamcinolone misc Systemic Corticosteroid misc Daclizumab
topic_browse	misc Asthma misc Salbutamol misc Triamcinolone misc Systemic Corticosteroid misc Daclizumab
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Daclizumab improves control of chronic persistent asthma
ctrlnum	(DE-627)SPR03518681X (SPR)00128413-200414370-00020-e
title_full	Daclizumab improves control of chronic persistent asthma
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2004
contenttype_str_mv	txt
container_start_page	9
container_volume	1437
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200414370-00020
title_sort	daclizumab improves control of chronic persistent asthma
title_auth	Daclizumab improves control of chronic persistent asthma
abstract	© Adis International Ltd 2004
abstractGer	© Adis International Ltd 2004
abstract_unstemmed	© Adis International Ltd 2004
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Daclizumab improves control of chronic persistent asthma
url	https://dx.doi.org/10.2165/00128413-200414370-00020
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200414370-00020
up_date	2024-07-03T13:49:41.358Z
_version_	1803566009667289088
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03518681X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520004635.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2004 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200414370-00020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03518681X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200414370-00020-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Daclizumab improves control of chronic persistent asthma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2004</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2004</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Asthma</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Salbutamol</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Triamcinolone</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Systemic Corticosteroid</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Daclizumab</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1437(2004), 1 vom: Mai, Seite 9-10</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1437</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:9-10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200414370-00020</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1437</subfield><subfield code="j">2004</subfield><subfield code="e">1</subfield><subfield code="c">05</subfield><subfield code="h">9-10</subfield></datafield></record></collection>
score	7.398773

Nicht das Richtige dabei?

Schreiben Sie uns!

Daclizumab improves control of chronic persistent asthma

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?